Alzheimer Disease Clinical Trial Landscape — Evidence Summary from ClinicalTrials.gov

[fjcobu14]

Alzheimer Disease Clinical Trial Landscape Analysis

This issue tracks the clinical trial landscape for Alzheimer Disease on ClinicalTrials.gov.

Summary Statistics

Total Studies: 4190

Status Distribution:

• COMPLETED: 2228
• RECRUITING: 610
• UNKNOWN: 486
• TERMINATED: 313
• ACTIVE_NOT_RECRUITING: 169
• NOT_YET_RECRUITING: 197
• WITHDRAWN: 103
• ENROLLING_BY_INVITATION: 71
• SUSPENDED: 7
• NO_LONGER_AVAILABLE: 4
• AVAILABLE: 2

Phase Distribution:

• NA: 1535
• PHASE2: 765
• Unknown: 882
• PHASE1: 594
• PHASE3: 382
• EARLY_PHASE1: 67
• PHASE4: 140

Key Observations

1. Over half of all Alzheimer Disease trials (2228 out of 4190) have been completed.
2. 610 trials are currently recruiting participants.
3. Phase 2 trials (765) represent the largest categorized phase group, followed by Phase 1 (594) and Phase 3 (382).
4. The knowledge graph identifies researcher Chen Zhang as a Person entity who leads medical research studies, providing pediatric consultations, organizing community health fairs, and serving as a public health speaker.

Related

• See issue Clinical Research Evidence: Music Therapy Outcomes for Dementia — Feature Guidance from ClinicalTrials.gov #34 for Music Therapy Outcomes for Dementia clinical trial evidence.